Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 8/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.71 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.71 |
| ▸ | TSHR | P16473 | 1/20 | 0.71 |
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | PKM | P14618 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | TTR | P02766 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Flunixin SCHEMBL42911 | 1.00 | DHODH (1.00) | DHODHHDAC6CYP1A2HIF1ATSHR | |
| Flunixin SCHEMBL31696761 | 1.00 | DHODH (1.00) | DHODHHDAC6CYP1A2HIF1ATSHR | |
| Flunixin SCHEMBL8325584 | 1.00 | DHODH (1.00) | DHODHHDAC6CYP1A2HIF1ATSHR | |
| Flunixin SCHEMBL28754969 | 0.99 | DHODH (0.98) | DHODHHDAC6CYP1A2HIF1ATSHR | |
| Flunixin SCHEMBL4117904 | 0.99 | DHODH (0.98) | DHODHHDAC6CYP1A2HIF1ATSHR | |
| Flunixin SCHEMBL28644103 | 0.98 | DHODH (0.95) | DHODHHDAC6CYP1A2HIF1ATSHR | |
| Flunixin SCHEMBL27694863 | 0.95 | DHODH (0.91) | DHODHHDAC6CYP1A2HIF1ATSHR | |
| Flunixin SCHEMBL7164324 | 0.93 | DHODH (0.87) | DHODHHDAC6CYP1A2HIF1ATSHR | |
| Flunixin SCHEMBL29811437 | 0.92 | DHODH (0.84) | DHODHHDAC6CYP1A2HIF1ATSHR | |
| SCHEMBL11485538 | 0.88 | DHODH (0.78) | DHODHHDAC6CYP1A2HIF1ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-3699174-B1 | COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME | ILAB (KR) | 2025-11-12 | — | — | EP | claimed |
| EP-4518682-A1 | USE OF NON-THERAPEUTIC ANTI-INFLAMMATORY MOLECULES IN PIGS | Vetoquinol SA (FR) | 2025-03-12 | — | — | EP | claimed |
| EP-3946461-B1 | XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF | UNIV BRITISH COLUMBIA (CA) | 2025-01-15 | — | — | EP | claimed |
| CN-116813537-B | Preparation method and application of novel flunixin hapten | 深圳市绿诗源生物技术有限公司 | 2024-09-17 | — | — | CN | claimed |
| WO-2023214131-A1 | USE OF NON-THERAPEUTIC ANTI-INFLAMMATORY MOLECULES IN PIGS | VETOQUINOL SA (FR) | 2023-11-09 | — | — | WO | claimed |
| CN-110327294-B | Compound long-acting injection containing enrofloxacin and flunixin and preparation method thereof | 南京农业大学 | 2023-06-13 | — | — | CN | claimed |
| CN-115710217-B | Flunixin meglumine synthesis method suitable for industrial production | 江苏恒盛药业有限公司 | 2025-06-13 | — | — | CN | disclosed |
| WO-2025122600-A1 | COMPOSITIONS AND METHODS FOR TREATING ABERRANT NITROSYLATION | CASE WESTERN RESERVE UNIVERSITY (US) | 2025-06-12 | — | — | WO | disclosed |
| EP-4518682-A1 | USE OF NON-THERAPEUTIC ANTI-INFLAMMATORY MOLECULES IN PIGS | Vetoquinol SA (FR) | 2025-03-12 | — | — | EP | disclosed |
| CN-222259316-U | PH detection and adjustment system for flunixin synthesis | 通辽华旭药业有限公司 | 2024-12-27 | — | — | CN | disclosed |
| EP-4466251-A1 | TREATMENT OF SIGNS, SYMPTOMS AND/OR COMPLICATIONS OF VIRAL, BACTERIAL, PROTOZOAL, AND/OR FUNGAL INFECTIONS BY HIGH PENETRATION PRODRUGS | TECHFIELDS INC. (US) | 2024-11-27 | — | — | EP | disclosed |
| CN-118515773-B | Sulfonamide monoclonal antibody, detection test strip and application thereof | 北京纳百生物科技有限公司 | 2024-10-08 | — | — | CN | disclosed |
| WO-2022173818-A1 | USE OF BILIVERDIN REDUCTASE B INHIBITORS TO ALLOW MALARIA ERADICATION IN PATIENTS WITH G6PD DEFICIENCY | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2022-08-18 | — | — | WO | disclosed |
| WO-2022173818-A1 | USE OF BILIVERDIN REDUCTASE B INHIBITORS TO ALLOW MALARIA ERADICATION IN PATIENTS WITH G6PD DEFICIENCY | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2022-08-18 | — | — | WO | disclosed |
| CN-114828897-A | Modulation of cell viability | 麦考瑞大学 | 2022-07-29 | — | — | CN | disclosed |
| CN-114716390-A | Compositions and methods for treating and/or preventing necrosis of cells or tissue | ELA制药有限公司 | 2022-07-08 | — | — | CN | disclosed |
| WO-2022112277-A1 | METHOD OF TREATMENT OF PAIN THROUGH BUCCAL ADMINISTRATION OF FLUNIXIN | INTERVET INTERNATIONAL B.V. (NL) | 2022-06-02 | — | — | WO | disclosed |
| CN-114269324-A | Isoxazoline anthelmintic formulations and methods for treating blepharitis | 塔苏斯制药有限公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-109010916-B | Moldable formulations containing oxysterol in acellular tissue matrices | 华沙整形外科股份有限公司 | 2022-03-04 | — | — | CN | disclosed |